Mineralys Therapeutics, Inc. ($MLYS)
Rodman David Malcom โ Chief Medical Officer
Shares
417
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 11, 2026
EPS:Est: -0.57
Feb 18, 2026
EPS:Est: -0.57
Transaction Details
| Insider | Rodman David Malcom |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Feb 17, 2026 |
| Expiration Date | Mar 17, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 17, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 417 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 5,417 |
| Derivative | Derivative |
| Accession Number | 0001672659-26-000013 |
| Document | View SEC Filing |